Zobrazeno 1 - 10
of 340
pro vyhledávání: ''
Autor:
Riichiroh Maruyama, Shinji Akamine, Jiichiro Sasaki, Hideki Hirata, Tatsuro Okamoto, Noriyuki Ebi, Yuichi Inoue, Jun Araki, Takashi Seto, Masafumi Yamaguchi, Hiroshi Semba
Publikováno v:
Japanese Journal of Clinical Oncology. 50:318-324
Objective Concurrent chemoradiotherapy is the standard treatment for locally advanced non-small cell lung cancer. In the current aging society, the establishment of an ideal treatment strategy for locally advanced non-small cell lung cancer in the el
Autor:
K. Niraimathi, Channappa N Patil, Satish Kumar Anumula, Prasad Gunari, Karthik S Udupa, Neelesh Reddy, S. Ganapathi Raman, Shashidhar V. Karpurmath, Murugesan Janarthinakani, Parameswaran Anoop, Manjunath Nandennavar, Arun Seshachalam, Bharath Rangarajan, Krishnakumar Rathnam, Sirigeri Prabhakar Roopa, Basawantrao Malipatil, Krishna Prasad, Krishna Reddy Golamari, Madhav Danthala, Hemant Deepak Shewade
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-13 (2019)
Journal of Global Oncology
Journal of Global Oncology
PURPOSE Escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) improves overall survival (OS) in patients with Hodgkin lymphoma (HL) relative to ABVD (doxorubicin, bleomycin, vinblastine, an
Autor:
Takanori Hazeyama, Mikio Nakamura, Kazuyoshi Uchihashi, Yujo Kawashita, Shigehisa Aoki, Hiroki Moriuchi, Masaki Tateishi, Junzo Yamaguchi, Takashi Ueda
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Background Interactions between adipocyte and breast cancer (BC) cells have yet to be fully elucidated. Here we investigated the prognostic impact of marginal adipose tissue invasion in both luminal breast cancer (HR+/HER2-) and triple-negative breas
Publikováno v:
Oncology Research
Apatinib is an oral TKI with antiangiogenic properties, and it is currently approved for the treatment of advanced gastric cancer in China. This agent has also been tested in other human solid tumors, including non-small cell lung cancer (NSCLC). Sin
Autor:
Filippo de Braud, Mirko Marabese, Elisa Caiola, Giancarlo Pruneri, Valter Torri, Monica Ganzinelli, Elena Tamborini, Rosaria Gallucci, Giulia Galli, Mario P. Colombo, Massimo Moro, Marina Chiara Garassino, Alessandra Fabbri, Gabriella Sozzi, Angela Maria Rizzo, Lital Hollander, Diego Signorelli, Tiziana Triulzi, Massimo Broggini, Giulia Vandoni, Paola Antonia Corsetto, Cecilia Gavazzi, Claudio Vernieri
Publikováno v:
Clinical Lung Cancer. 20:e413-e417
Advanced lung adenocarcinoma with inactive liver kinase B1 (LKB1) tumor suppressor protein is associated with poor response to immune checkpoint inhibitors and molecularly targeted agents, and with dismal patient prognosis. LKB1 is a central orchestr
Autor:
Corinna Elender, Claus-Christoph Steffens, Stephanie Dille, L. Spring, Norbert Marschner, Ulrich Hutzschenreuter, Martina Jänicke, Adrian Binninger
Publikováno v:
Lung Cancer. 130:216-225
Objectives Despite intensive research, the therapeutic options in extensive-stage small cell lung cancer (SCLC) are still limited. Data from routine clinical practice, so-called “real-world data”, are centrally important to assess and improve the
Autor:
Ninette Amariglio, Itay Zilbershats, Noam Benyamini, Gabriela Rozic, Luba Trakhtenbrot, Merav Leiba, Olga Shevetz, Adrian Duek, Ronit Leiba, Arnon Nagler, Chezi Ganzel
Publikováno v:
Genes, Chromosomes and Cancer. 58:516-520
The current study evaluated the prognostic significance of the monoallelic deletion of the whole locus of the immunoglobulin heavy-chain (w_del(IGH)) gene compared to translocations t(4;14) and t(14;16) among newly diagnosed multiple myeloma (MM) pat
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer
BMC Cancer
Background Hepatocellular carcinoma (HCC) is a common cancer worldwide, with a poor prognosis. Most patients are diagnosed at advanced stages and are only eligible for palliative therapy. Therefore, this study aimed to evaluate the safety and efficac
Autor:
Tomonori Tanei, Masafumi Shimoda, Naofumi Kagara, Tomohiro Miyake, Kenzo Shimazu, Ako Ohara, Shinzaburo Noguchi, Yasuto Naoi, Seung Jin Kim
Publikováno v:
Breast Cancer Research and Treatment. 173:533-543
There is an urgent need for the development of a predictor of response to chemotherapy for ER-positive breast cancer which is less chemosensitive than for ER-negative breast cancer in order to avoid unnecessary chemotherapy. In the present study, int
Autor:
Torben Riis Rasmussen, Susanne Oksbjerg Dalton, Anders Løkke, Jane Christensen, Niels Lyhne Christensen
Publikováno v:
Christensen, N L, Løkke, A, Dalton, S O & Rasmussen, T R 2018, ' Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients ', Lung Cancer, vol. 124, pp. 40-44 . https://doi.org/10.1016/j.lungcan.2018.07.025
Introduction In addition to the highest incidence rate of lung cancer among the Nordic countries, Denmark has the highest mortality rate. Moreover, rates of tobacco and alcohol consumption are among the highest in these countries. Method In a populat